Nitric oxide-releasing mesalamine: potential utility for treatment of inflammatory bowel disease

被引：15
|
作者：
Wallace, JL [1 ]
机构：
[1] Univ Calgary, Mucosal Inflammat Res Grp, Calgary, AB T2N 4N1, Canada
来源：
DIGESTIVE AND LIVER DISEASE | 2003年 / 35卷
关键词：
aminosalicylic acid; colitis inflammation; inflammatory bowel disease;
D O I：
10.1016/S1590-8658(03)00050-1
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Nitric oxide can accelerate ulcer healing and exert anti-inflammatory effects. Addition of a nitric oxide-releasing moiety to mesalamine significantly boosts its anti-inflammatory activity. NO-releasing mesalamine suppresses inflammatory cytokine production and reduces leukocyte infiltration. (C) 2003 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码：S35 / S40
页数：6
相关论文
共 50 条
  • [1] Nitric oxide as a potential biomarker in inflammatory bowel disease
    Avdagic, Nesina
    Zaciragic, Asija
    Babic, Nermina
    Hukic, Mirsada
    Seremet, Mensura
    Lepara, Orhan
    Nakas-Icindic, Emma
    BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2013, 13 (01) : 5 - 9
  • [2] Oxymatrine loaded nitric oxide-releasing liposomes for the treatment of ulcerative colitis
    Tang, Qing
    Zhang, Wei
    Zhang, Chong
    Guan, Yang
    Ding, Jiahui
    Yuan, Caiyan
    Tan, Chen
    Gao, Xueqin
    Tan, Songwei
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2020, 586
  • [3] Diarrhea as a side effect of mesalamine treatment for inflammatory bowel disease
    Goldstein, F
    DiMarino, AJ
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2000, 31 (01) : 60 - 62
  • [4] Nitric oxide and inflammatory bowel disease.
    García-González, MA
    Pena, AS
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 1998, 90 (12) : 870 - 876
  • [5] Expression of nitric oxide synthase in inflammatory bowel disease is not affected by corticosteroid treatment
    Leonard, N
    Bishop, AE
    Polak, JM
    Talbot, IC
    JOURNAL OF CLINICAL PATHOLOGY, 1998, 51 (10) : 750 - 753
  • [6] Potential of phytomedicine in the treatment of inflammatory bowel disease
    Jie Tang
    Dong Xu
    Xin-Ran Dong
    Yi-Lun Wang
    Kun-Tang Wang
    Yue Wang
    Tao Qiao
    Yuan-Lu Cui
    Phytochemistry Reviews, 2022, 21 : 709 - 724
  • [7] Mucoadhesive Mesalamine Prodrug Nanoassemblies to Target Intestinal Macrophages for the Treatment of Inflammatory Bowel Disease
    Park, Byeongmin
    Han, Geonhee
    Jin, Do Young
    Gil, Ki Cheol
    Shin, Dongwon
    Lee, Jongwon
    Park, Jung Yeon
    Jang, Hochung
    Park, Daeho
    Lee, Sangmin
    Kim, Kwangmeyung
    Yang, Yoosoo
    Kim, Yongju
    Kim, Jun-Seob
    Kim, Sun Hwa
    Shim, Man Kyu
    ACS NANO, 2024, 18 (25) : 16297 - 16311
  • [8] Potential of phytomedicine in the treatment of inflammatory bowel disease
    Tang, Jie
    Xu, Dong
    Dong, Xin-Ran
    Wang, Yi-Lun
    Wang, Kun-Tang
    Wang, Yue
    Qiao, Tao
    Cui, Yuan-Lu
    PHYTOCHEMISTRY REVIEWS, 2022, 21 (03) : 709 - 724
  • [9] Rectal nitric oxide in the treatment of inflammatory bowel disease:: responders vs non-responders
    Lundberg, S.
    Holst, M.
    Hellstrom, P. M.
    ACTA PHYSIOLOGICA, 2006, 187 (04) : 489 - 494
  • [10] Mesalamine Protects Against Colorectal Cancer in Inflammatory Bowel Disease
    Jeffrey Tang
    Omar Sharif
    Chetan Pai
    Ann L. Silverman
    Digestive Diseases and Sciences, 2010, 55 : 1696 - 1703
12345